133 related articles for article (PubMed ID: 6352661)
1. A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia.
Mandell LA; Nicolle LE; Ronald AR; Duperval R; Robson HG; Feld R; Vincelette J; Fong I
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():9-20. PubMed ID: 6352661
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia.
Mandell LA; Nicolle LE; Ronald AR; Landis SJ; Duperval R; Harding GK; Robson HG; Feld R; Vincelette J; Fong I
J Antimicrob Chemother; 1987 Jul; 20(1):95-107. PubMed ID: 3305464
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effectiveness of ceftazidime and cefazolin/tobramycin in patients with inflammatory diseases of the lower respiratory tract].
Vetter N; Feist H; Armbruster C; Drlicek M
Infection; 1987; 15 Suppl 4():S192-4. PubMed ID: 3312033
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the efficacy of ceftazidime versus cefazolin and tobramycin in patients with acute exacerbations of chronic bronchitis.
Vetter N; Feist H; Muhar F; Williams KJ
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():35-9. PubMed ID: 6352642
[TBL] [Abstract][Full Text] [Related]
5. [Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
Kljucar S; Heimesaat M; von Pritzbuer E; Olms K
Infection; 1987; 15 Suppl 4():S185-91. PubMed ID: 3312032
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
Fainstein V; Bodey GP; Elting L; Bolivar R; Keating MJ; McCredie KB; Valdivieso M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():101-10. PubMed ID: 6352612
[TBL] [Abstract][Full Text] [Related]
7. Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study.
Madsen PO; Frimodt-Møller PC
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():77-9. PubMed ID: 6352658
[TBL] [Abstract][Full Text] [Related]
8. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
Cox CE
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
[TBL] [Abstract][Full Text] [Related]
9. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
Sieger B; Berman SJ; Geckler RW; Farkas SA
Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime as a single agent in the management of children with fever and neutropenia.
Morgan G; Duerden BI; Lilleyman JS
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():347-51. PubMed ID: 6352641
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Baker RS; Flowers CW; Casey R; Fong DS; Wilson MR
Arch Ophthalmol; 1996 May; 114(5):632-3. PubMed ID: 8619784
[No Abstract] [Full Text] [Related]
12. Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
Cone LA; Woodard DR; Stoltzman DS; Byrd RG
Antimicrob Agents Chemother; 1985 Jul; 28(1):33-6. PubMed ID: 3899005
[TBL] [Abstract][Full Text] [Related]
13. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
Duma RJ
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
[No Abstract] [Full Text] [Related]
14. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Bezwoda WR; Derman DP; Perkins S; Cassel R
J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
Bakker-Woudenberg IA; van den Berg JC; Michel MF
Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
[TBL] [Abstract][Full Text] [Related]
16. Treatment of twelve burn wound infections and eight other serious infections with cefazolin and tobramycin: in vitro and in vivo evaluation.
Franson TR; Edwards LD; Collins RF; Root TE
Chemotherapy; 1980; 26(5):384-96. PubMed ID: 7389430
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with cefazolin: a new cephalosporin antibiotic.
Hammer GS; Ribner BS; Meyers BR; Hirschman SZ
Mt Sinai J Med; 1975; 42(2):142-9. PubMed ID: 1079566
[No Abstract] [Full Text] [Related]
18. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin.
Frimodt-Møller PC; Madsen PO
J Urol; 1983 Oct; 130(4):796-7. PubMed ID: 6350625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
